The Neuroprotective Potentiality of Flavonoids on Alzheimer's Disease.
Antonella CalderaroGiuseppe Tancredi PatanèEster TelloneDavide BarrecaSilvana FicarraFrancesco MisitiGiuseppina LaganàPublished in: International journal of molecular sciences (2022)
Alzheimer's disease (AD), due to its spread, has become a global health priority, and is characterized by senile dementia and progressive disability. The main cause of AD and other neurodegenerations (Huntington, Parkinson, Amyotrophic Lateral Sclerosis) are aggregated protein accumulation and oxidative damage. Recent research on secondary metabolites of plants such as polyphenols demonstrated that they may slow the progression of AD. The flavonoids' mechanism of action in AD involved the inhibition of acetylcholinesterase, butyrylcholinesterase, Tau protein aggregation, β-secretase, oxidative stress, inflammation, and apoptosis through modulation of signaling pathways which are implicated in cognitive and neuroprotective functions, such as ERK, PI3-kinase/Akt, NFKB, MAPKs, and endogenous antioxidant enzymatic systems. This review focuses on flavonoids and their role in AD, in terms of therapeutic potentiality for human health, antioxidant potential, and specific AD molecular targets.
Keyphrases
- oxidative stress
- human health
- signaling pathway
- amyotrophic lateral sclerosis
- global health
- risk assessment
- multiple sclerosis
- cell proliferation
- induced apoptosis
- dna damage
- climate change
- diabetic rats
- mild cognitive impairment
- cognitive decline
- cell death
- pi k akt
- public health
- ms ms
- protein protein
- cell cycle arrest
- cerebral ischemia
- tyrosine kinase
- brain injury
- nitric oxide
- small molecule
- blood brain barrier
- binding protein